IFN-β interferes with the differentiation of dendritic cells from peripheral blood mononuclear cells:: Selective inhibition of CD40-dependent interleukin-12 secretion

被引:35
作者
Bartholomé, EJ
Willems, F
Crusiaux, A
Thielemans, K
Schandene, L
Goldman, M
机构
[1] Hop Erasme, Dept Immunol, B-1070 Brussels, Belgium
[2] Free Univ Brussels, Ctr Rech Interuniv Vaccinol, Brussels, Belgium
[3] Free Univ Brussels, Lab Physiol Immunol, Brussels, Belgium
关键词
D O I
10.1089/107999099313910
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We studied the effects of interferon-beta (IFN-beta) on the differentiation of dendritic cells (DC) obtained by culturing plastic-adherent peripheral blood mononuclear cells (PBMC) from a total of 30 healthy volunteers in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4). First, we found that the addition of IFN-beta at the initiation of the culture did not modify DC morphology but caused a reproducible and statistically significant upregulation of HLA-DR, CD86, and CD80 surface expression. CD1a expression was significantly reduced, and CD40 expression was unchanged. We then determined the influence of IFN-beta on the production of cytokines by DC. DC differentiated in the presence of IFN-beta secreted significantly less IL-12 (p40 and p70) both spontaneously and on activation by fibroblasts transfected with the CD40L gene. This effect of IFN-beta was dose dependent and selective, as it was not observed for IL-6, IL-8, and tumor necrosis factor-alpha (TNF-alpha). As a consequence, DC differentiated in the presence of IFN-beta induced significantly less IFN-gamma secretion by alloreactive T cells, whereas they were more efficient than control DC in eliciting IL-5 secretion. We conclude that the direct action of IFN-beta on DC causes inhibition of their ability to secrete IL-12 in response to CD40 ligation and to elicit Th1 type responses.
引用
收藏
页码:471 / 478
页数:8
相关论文
共 52 条
[41]   PROLIFERATING DENDRITIC CELL PROGENITORS IN HUMAN BLOOD [J].
ROMANI, N ;
GRUNER, S ;
BRANG, D ;
KAMPGEN, E ;
LENZ, A ;
TROCKENBACHER, B ;
KONWALINKA, G ;
FRITSCH, PO ;
STEINMAN, RM ;
SCHULER, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :83-93
[42]   Generation of mature dendritic cells from human blood - An improved method with special regard to clinical applicability [J].
Romani, N ;
Reider, D ;
Heuer, M ;
Ebner, S ;
Kampgen, E ;
Eibl, B ;
Niederwieser, D ;
Schuler, G .
JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 196 (02) :137-151
[43]   Recombinant interferon-alpha selectively inhibits the production interleukin-5 by human CD4(+) T cells [J].
Schandene, L ;
DelPrete, GF ;
Cogan, E ;
Stordeur, P ;
Crusiaux, A ;
Kennes, B ;
Romagnani, S ;
Goldman, M .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (02) :309-315
[44]  
SPEAR GT, 1987, CLIN EXP IMMUNOL, V69, P107
[45]   REGULATION OF HUMAN PERIPHERAL-BLOOD MONOCYTE DR ANTIGEN EXPRESSION INVITRO BY LYMPHOKINES AND RECOMBINANT INTERFERONS [J].
SZTEIN, MB ;
STEEG, PS ;
JOHNSON, HM ;
OPPENHEIM, JJ .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (02) :556-565
[46]   Dendritic cells generated from human blood in granulocyte macrophage-colony stimulating factor and interleukin-7 [J].
Takahashi, K ;
Honeyman, MC ;
Harrison, LC .
HUMAN IMMUNOLOGY, 1997, 55 (02) :103-116
[47]  
THOMAS R, 1993, J IMMUNOL, V151, P6840
[48]   New insights into the mechanisms of interferon alfa: An immunoregulatory and anti-inflammatory cytokine [J].
Tilg, H .
GASTROENTEROLOGY, 1997, 112 (03) :1017-1021
[49]  
Verhasselt V, 1997, J IMMUNOL, V158, P2919
[50]  
Wenner CA, 1996, J IMMUNOL, V156, P1442